FIELD: pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutics and is a composition for treating oncological diseases in the form of phospholipid nanoparticles of less than 50 nm in size, including phytogenous phosphatidylcholine, maltose and decyl sarcolysin ester in following ratio of components, wt%: phosphatidylcholine 20–42; maltose 56–73; decyl sarcolysine ester 2–7.
EFFECT: invention provides a wider range of compositions for treating cancer and lesser side effects of sarcolysin.
1 cl, 2 ex, 3 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
PHOSPHOLIPID COMPOSITION OF DOXORUBICIN FOR TREATING PATIENTS WITH BREAST CANCER | 2019 |
|
RU2714137C1 |
PHARMACEUTICAL COMPOSITION BASED ON DOXORUBICINE AND PHOSPHOLIPID NANOPARTICLES FOR TREATMENT OF ONCOLOGIC DISEASES | 2009 |
|
RU2411935C1 |
BASED ON BOTANICAL PHOSPHOLIPIDS NANOSYSTEM FOR ACTUATION OF BIOLOGICALLY ACTIVE COMPOUNDS, AND METHOD OF ITS MANUFACTURE (VERSIONS) | 2009 |
|
RU2391966C1 |
PHOSPHOLIPID THERAPEUTIC COMPOSITION WITH NANO-SIZED PARTICLES FOR LIPID STORAGE DISEASE AND COMATOSE STATES AND METHOD FOR PREPARING IT | 2010 |
|
RU2448715C1 |
PHARMACEUTIC COMPOSITION INCLUDING ARBIDOL IN COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | 2009 |
|
RU2411942C2 |
COMPOSITION OF DIHYDROQUERCETINE ENCLOSED IN PHOSPHOLIPID NANOPARTICLES | 2013 |
|
RU2536208C1 |
METHOD FOR PRODUCING COMPOSITION FOR PHOTODYNAMIC THERAPY IN FORM OF PHOSPHOLIPID NANOPARTICLES BASED ON GLUCAMINE CHLORINE E6 SALT, MALTOSE AND PHOSPHATIDYLCHOLINE | 2014 |
|
RU2576025C1 |
PHOSPHOLIPID NANOPARTICLE INDOMETACIN APPLICABLE IN OPHTHALMOLOGY | 2011 |
|
RU2456979C1 |
ANTITUBERCULOUS COMPOSITION AND METHOD FOR PREPARING IT | 2011 |
|
RU2472512C1 |
ANTITUMOUR AGENT FOR TREATING PROSTATE CANCER IN THE FORM OF SACHET | 2018 |
|
RU2695326C1 |
Authors
Dates
2018-07-23—Published
2017-05-29—Filed